BRP, a peptide related to BRINP2, exhibits anti-obesity activity through the activation of FOS. It triggers FOS activation in the central nervous system, and its effect is independent of leptin, GLP-1 receptor, and melanocortin 4 receptor.
Target:
DNA/RNA Synthesis
* VAT and and shipping costs not included. Errors and price changes excepted